week in cancer news

A study shows that the rate of death following bone marrow transplant has decreased, and the U.S. Food and Drug Administration approves a new treatment for patients with a rare form of sarcoma.

by Kate Yandell

A study shows that eating more vegetables does not reduce risk of progression for patients with early-stage prostate cancer, and a new website provides information on cancer survival rates.

by Kate Yandell

The rate of cancer deaths in the U.S. has continued to decline, and the U.S. Food and Drug Administration approves a new treatment for a rare cancer type.

by Kate Yandell

When reading mammograms, an artificial intelligence system yields fewer false-positive and false-negative results than radiologists, and the U.S. Food and Drug Administration approves a targeted therapy for pancreatic cancer.

by Kate Yandell

Stool-based colorectal cancer screening may come with unexpected costs, and losing weight is associated with reduced breast cancer risk in postmenopausal women.

by Kate Yandell

Hispanics living in the U.S. are at increased risk of being diagnosed with and dying from cervical cancer, and a cancer researcher and survivor writes about the problem with focusing on one universal cancer cure.

by Kate Yandell

A study suggests an association between hair dye use and breast cancer, and the U.S. Food and Drug Administration adds a new indication for an immunotherapy-chemotherapy combination.

by Kate Yandell

Data from Northern Ireland suggest a fifth of cancer diagnoses are made in the emergency department, and a study investigates how the nervous system might be harnessed for cancer treatment.

by Bradley Jones

A study suggests the rate of melanoma diagnoses in adolescents and young adults is falling, and a health care reporter writes about the many difficult decisions she had to make after her cancer diagnosis.

by Kate Yandell

Some oncologists do not discuss the costs of genomic testing and resulting treatments with their patients, and preliminary results indicate that a cancer therapy using the CRISPR gene-editing technique is safe.

by Kate Yandell